Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany von Vijayaraghavan, Arthi, Efrusy, Molly B., Göke, Burkhard, Kirchner, Thomas, Santas, Christopher C., Goldberg, Richard M.

Volltext

Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening von Vijayaraghavan, Arthi, Efrusy, Molly B, Goodman, Karyn A, Santas, Christopher C, Huh, Warner K

Volltext

Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Québec, Canada von Vijayaraghavan, Arthi, Efrusy, Molly B., Mayrand, Marie-Hélène, Santas, Christopher C., Goggin, Patricia

Volltext

Cost-Effectiveness of Alternative Strategies for Initiating and Monitoring Highly Active Antiretroviral Therapy in the Developing World von Vijayaraghavan, Arthi, Efrusy, Molly Bates, Mazonson, Peter D, Ebrahim, Osman, Sanne, Ian M, Santas, Christopher C

Volltext

Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa von Vijayaraghavan, Arthi, Efrusy, Molly, Lindeque, Gerhard, Dreyer, Greta, Santas, Christopher

Volltext

The HI-STAR study: resource utilization and costs associated with serologic testing for antibody-positive patients at four United States medical centers von Mazonson, Peter, Efrusy, Molly, Santas, Chris, Ziman, Alyssa, Burner, James, Roseff, Susan, Vijayaraghavan, Arthi, Kaufman, Richard

Volltext

The HI‐STAR study: resource utilization and costs associated with serologic testing for antibody‐positive patients at four U nited S tates medical centers von Mazonson, Peter, Efrusy, Molly, Santas, Chris, Ziman, Alyssa, Burner, James, Roseff, Susan, Vijayaraghavan, Arthi, Kaufman, Richard

Volltext